Davidson Michael H.

CIK 00015737856 companiesNAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001573785

Recent Transactions

50 trades

Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-03-02+443,707→ 617,851 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-03-02−443,707→ 239,267 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-03-02$33.25/sh−443,707→ 174,144 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-26$33.63/sh−165,408→ 477,783 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-26+183,332→ 643,191 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-02-26−183,332→ 682,974 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-26$34.44/sh−17,924→ 174,144 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-25$35.11/sh−46,517→ 471,595 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-25$35.96/sh−10,436→ 461,159 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-25+58,253→ 518,112 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-02-25−58,253→ 866,306 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-25$36.68/sh−1,300→ 459,859 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-24+64,708→ 524,567 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-02-24−64,708→ 924,559 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-24$36.46/sh−3,161→ 459,859 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-02-24$36.13/sh−61,547→ 463,020 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2026-01-09+30,000→ 30,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-07+81,000→ 459,859 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2026-01-07−11,582→ 378,859 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2026-01-07+364,000→ 364,000 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2025-07-01+80,000→ 80,000 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2025-06-05+22,000→ 22,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26+30,992→ 364,305 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26−38,394→ 0 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26+38,394→ 402,699 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26−12,258→ 390,441 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26+38,394→ 38,394 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-07+123,529→ 123,529 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-06+670,467→ 670,467 total
Award
Silence Therapeutics plc$SLN
Share Option (Right to Buy)
2025-01-02+48,000→ 48,000 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2024-12-10+100,000→ 100,000 total
Gift
NewAmsterdam Pharma Co N.V.$NAMS
Warrant (right to buy)
2024-10-09$11.50/sh−15,000→ 85,000 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2024-09-25+15,000→ 15,000 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2024-08-20$16.27/sh+5,000→ 209,784 total
Purchase
TENAX THERAPEUTICS, INC.$TENX
Common Stock
2024-08-08+2,500→ 2,881 total
Purchase
TENAX THERAPEUTICS, INC.$TENX
Pre-Funded Warrant
2024-08-08+47,500→ 47,500 total
Purchase
TENAX THERAPEUTICS, INC.$TENX
Warrant
2024-08-08+25,000→ 25,000 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2024-06-20$17.26/sh+5,000→ 204,784 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2024-03-26+33,986→ 33,986 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2024-01-01+1,039,939→ 1,039,939 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2022-06-09+5,000→ 5,000 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2022-01-10+65,430→ 209,753 total
Exercise/Conversion
TENAX THERAPEUTICS, INC.$TENX
Series B Preferred Stock
2021-06-11−512→ 0 total
Award
TENAX THERAPEUTICS, INC.$TENX
Common Stock
2021-06-11+512,000→ 606,645 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2021-06-10+6,250→ 6,250 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2021-01-11+37,735→ 144,323 total
Purchase
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2020-09-09$1.80/sh+55,525→ 106,588 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2020-07-28$2.35/sh+51,063→ 51,063 total
Disposition to Issuer
Omthera Pharmaceuticals, Inc.
Common Stock
2013-07-18−964,587→ 0 total
Disposition to Issuer
Omthera Pharmaceuticals, Inc.
Common Stock
2013-07-18−520,756→ 0 total

Companies

Recent Filings

Address

C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35

NAARDEN, P7, 1411 DC

View on SEC.gov